PCI acquisition of Bellwyck Pharma Services
Acquisition11/02/2020
PCI announced its acquisition of Toronto-based Bellwyck Pharma Services, adding clinical-trial and commercial packaging, labeling and logistics facilities in Canada, Germany and the United States. The historical operating-group announcement does not disclose a purchase price.
Type
Acquisition
Announced
11/02/2020
Amount
Financial data requires access
Reported parties
PCI Pharma Services,Bellwyck Pharma Services